1. Crowson, CS, Liao, KP, Davis, JM, et al. Rheumatoid arthritis and cardiovascular disease. Am Heart J 2013; 166: 622–628.e1.
Google Scholar | Crossref | Medline | ISI2. Verhoeven, F, Prati, C, Demougeot, C, et al. Cardiovascular risk in psoriatic arthritis, a narrative review. Joint Bone Spine 2020; 87: 413–418.
Google Scholar | Crossref | Medline3. Liew, JW, Ramiro, S, Gensler, LS. Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis. Best Pract Res Clin Rheumatol 2018; 32: 369–389.
Google Scholar | Crossref | Medline4. Luchetti, MM, Benfaremo, D, Gabrielli, A. Biologics in inflammatory and immunomediated arthritis. Curr Pharm Biotechnol 2017; 18: 989–1007.
Google Scholar | Crossref | Medline5. Peters, MJ, Symmons, DP, McCarey, D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325–331.
Google Scholar | Crossref | Medline | ISI6. Molto, A, Etcheto, A, van der Heijde, D, et al. Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 2016; 75: 1016–1023.
Google Scholar | Crossref | Medline7. Mathieu, S, Soubrier, M. Cardiovascular events in ankylosing spondylitis: a 2018 meta-analysis. Ann Rheum Dis 2019; 78: e57.
Google Scholar | Crossref | Medline8. Roubille, C, Richer, V, Starnino, T, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2015; 74: 480–489.
Google Scholar | Crossref | Medline | ISI9. Tam, LS, Shang, Q, Kun, EW, et al. The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis-a randomized, placebo-controlled pilot trial. Rheumatology (Oxford) 2014; 53: 1065–1074.
Google Scholar | Crossref | Medline10. van Sijl, AM, van Eijk, IC, Peters, MJ, et al. Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis. Ann Rheum Dis 2015; 74: 119–123.
Google Scholar | Crossref | Medline | ISI11. Thygesen, K, Alpert, JS, Jaffe, AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 2018; 72: 2231–2264.
Google Scholar | Crossref | Medline12. van der Linden, S, Valkenburg, HA, Cats, A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361–368.
Google Scholar | Crossref | Medline13. Chau, PH, Woo, J, Goggins, WB, et al. Trends in stroke incidence in Hong Kong differ by stroke subtype. Cerebrovasc Dis 2011; 31: 138–146.
Google Scholar | Crossref | Medline14. Jiang, B, Wang, WZ, Chen, H, et al. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke 2006; 37: 63–68.
Google Scholar | Crossref | Medline | ISI15. Kim, RB, Kim, BG, Kim, YM, et al. Trends in the incidence of hospitalized acute myocardial infarction and stroke in Korea, 2006-2010. J Korean Med Sci 2013; 28: 16–24.
Google Scholar | Crossref | Medline16. Forouzanfar, MH, Moran, AE, Flaxman, AD, et al. Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Glob Heart 2012; 7: 331–42.
Google Scholar | Crossref17. Chung, CP, Oeser, A, Solus, J, et al. Inflammatory mechanisms affecting the lipid profile in patients with systemic lupus erythematosus. J Rheumatol 2007; 34: 1849–1854.
Google Scholar | Medline | ISI18. Gonzalez-Gay, MA, Gonzalez-Juanatey, C. Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox. Ann Rheum Dis 2014; 73: 1281–1283.
Google Scholar | Crossref | Medline | ISI19. van Halm, VP, van Denderen, JC, Peters, MJ, et al. Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 2006; 65: 1473–1477.
Google Scholar | Crossref | Medline20. Tam, LS, Gu, J, Yu, D. Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 2010; 6: 399–405.
Google Scholar | Crossref | Medline | ISI21. Borst, SE. The role of TNF-alpha in insulin resistance. Endocrine 2004; 23: 177–182.
Google Scholar | Crossref | Medline | ISI22. Hardardottir, I, Moser, AH, Memon, R, et al. Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res 1994; 13: 161–166.
Google Scholar | Medline23. Hansson, GK, Hermansson, A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204–212.
Google Scholar | Crossref | Medline | ISI24. IL6R Genetics Consortium Emerging Risk Factors Collaboration , Sarwar, N, Butterworth, AS, et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 2012; 379: 1205–1213.
Google Scholar | Crossref | Medline25. Duewell, P, Kono, H, Rayner, KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464: 1357–1361.
Google Scholar | Crossref | Medline | ISI26. Gerli, R, Bartoloni Bocci, E, Sherer, Y, et al. Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67: 724–725.
Google Scholar | Crossref | Medline27. Kerekes, G, Szekanecz, Z, Der, H, et al. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 2008; 35: 398–406.
Google Scholar | Medline | ISI28. Tsai, WC, Ou, TT, Yen, JH, et al. Long-term frequent use of non-steroidal anti-inflammatory drugs might protect patients with ankylosing spondylitis from cardiovascular diseases: a nationwide case-control study. PLoS One 2015; 10: e0126347.
Google Scholar | Crossref | Medline29. Dubreuil, M, Louie-Gao, Q, Peloquin, CE, et al. Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis. Ann Rheum Dis 2018; 77: 1137–1142.
Google Scholar | Medline30. Coxib and traditional NSAID Trialists’ (CNT) Collaboration , Bhala, N, Emberson, J, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013; 382: 769–779.
Google Scholar | Crossref | Medline | ISI31. Caughey, GE, Cleland, LG, Penglis, PS, et al. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J Immunol 2001; 167: 2831–2838.
Google Scholar | Crossref | Medline32. Varas-Lorenzo, C, Riera-Guardia, N, Calingaert, B, et al. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf 2011; 20: 1225–1236.
Google Scholar | Crossref | Medline | ISI33. Trelle, S, Reichenbach, S, Wandel, S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011; 342: c7086.
Google Scholar | Crossref | Medline34. Bally, M, Dendukuri, N, Rich, B, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ 2017; 357: j1909.
Google Scholar | Crossref | Medline35. Grigoriou, A, Ibrahim, F, Chaabo, K, et al. Cardiovascular risk with NSAIDs in rheumatoid arthritis: an analysis using routinely collected data. Rheumatology (Oxford) 2016; 55: 763–764.
Google Scholar | Crossref | Medline36. Tarp, S, Bartels, EM, Bliddal, H, et al. Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheum 2012; 64: 3511–3521.
Google Scholar | Crossref | Medline37. Kroon, FP, van der Burg, LR, Ramiro, S, et al. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev 2015; 7: CD010952.
Google Scholar38. van der Heijde, D, Ramiro, S, Landewe, R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 2017; 76: 978–991.
Google Scholar | Crossref | Medline | ISI39. Tam, HW, Yeo, KJ, Leong, PY, et al. Sulfasalazine might reduce risk of cardiovascular diseases in patients with ankylosing spondylitis: a nationwide population-based retrospective cohort study. Int J Rheum Dis 2017; 20: 363–370.
Google Scholar | Crossref | Medline40. Westlake, SL, Colebatch, AN, Baird, J, et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology (Oxford) 2010; 49: 295–307.
Google Scholar | Crossref | Medline | ISI41. Ridker, PM, Everett, BM, Pradhan, A, et al. Low-dose methotrexate for the prevention of atherosclerotic events. N Engl J Med 2019; 380: 752–762.
Google Scholar | Crossref | Medline42. Ridker, PM, Everett, BM, Thuren, T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017; 377: 1119–1131.
Google Scholar | Crossref | Medline | ISI43. Barnabe, C, Martin, BJ, Ghali, WA. Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011; 63: 522–529.
Google Scholar | Crossref | Medline | ISI44. Lee, JL, Sinnathurai, P, Buchbinder, R, et al. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study. Arthritis Res Ther 2018; 20: 171.
Google Scholar | Crossref | Medline45. Zardi, EM, Pipita, ME, Giorgi, C, et al. Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-alpha antagonists and healthy matched controls. Medicine (Baltimore) 2018; 97: e11250.
Google Scholar | Crossref | Medline46. Angel, K, Provan, SA, Gulseth, HL, et al. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension 2010; 55: 333–338.
Google Scholar | Crossref | Medline | ISI47. Heliovaara, M, Makela, M, Aromaa, A, et al. Low back pain and subsequent cardiovascular mortality. Spine (Phila Pa 1976) 1995; 20: 2109–2111.